World News: 13:00 GMT Saturday 8th December 2018. [Novartis International AG via Thomson Reuters ONE via SPi World News]
Novartis International AG Novartis data demonstrates consistent efficacy and tolerability of Kisqali combination therapy in HR+/HER2- advanced breast cancer in patients with difficult-to-treat visceral disease Processed and transmitted by W est Cor...
Thomson Reuters: 13:00 GMT Saturday 8th December 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.